Janice Kranz, Co-Founder

Professional Overview

Janice Kranz is an accomplished biotechnology leader with extensive expertise in drug development, scientific research, and innovative program management. As the Co-Founder of Eikonizo Therapeutics, she leverages her deep industry knowledge and strategic vision to drive the company's mission of developing transformative therapies.

Experience Summary

Current Role

As the Co-Founder of Eikonizo Therapeutics, Janice is responsible for providing strategic direction, overseeing operational activities, and fostering a collaborative culture that enables the company to achieve its ambitious goals. In her previous roles as Chief Scientific Officer and Chief Executive Officer, she successfully led the company's scientific and business operations, positioning Eikonizo as a rising star in the biotechnology landscape.

Career Progression

Janice's career spans over two decades, during which she has held various leadership positions in the biotechnology industry. Prior to co-founding Eikonizo, she served as the Grant Writer, Project Manager, and Research Informatics professional at Collaborative Drug Discovery - CDD VAULT, where she played a crucial role in securing funding and managing complex research initiatives. She also held the position of Assistant Director at the Stanley Center for Psychiatric Research at The Broad Institute of MIT and Harvard, where she contributed to groundbreaking research in the field of neuroscience.

Janice's diverse background includes stints as a Consultant, Pipeline Manager at ALS Therapy Development Institute, and Research Scientist at Cubist Pharmaceuticals, where she honed her expertise in drug development, project management, and scientific research.

Academic Background

Janice holds a Ph.D. in Molecular Biology from Brandeis University, where she conducted pioneering research and published extensively in peer-reviewed journals. Her academic excellence and dedication to advancing scientific knowledge have been recognized throughout her career.

Areas of Expertise

Janice's areas of expertise include drug discovery, translational research, scientific program management, grant writing, and strategic leadership. She has a proven track record of successfully navigating complex regulatory environments, securing funding, and driving the development of innovative therapeutics.

Professional Impact

Janice's contributions to the biotechnology industry have been significant. At Eikonizo Therapeutics, she has led the company's efforts to develop novel therapies targeting unmet medical needs, with a particular focus on rare and complex diseases. Her visionary leadership and collaborative approach have earned her recognition within the industry and among her peers.

Conclusion

Janice Kranz's extensive experience, scientific expertise, and strategic acumen make her a valuable asset in the biotechnology sector. As the Co-Founder of Eikonizo Therapeutics, she is poised to continue her pursuit of groundbreaking advancements that improve patient outcomes and transform lives.